- Chorus Aviation‘s operating revenue for the fourth quarter of 2024 was C$353.2 million, slightly above the estimate of C$351.8 million.
- The company’s adjusted EBITDA from continuing operations was C$52.7 million, which was slightly below the expected C$53.9 million.
- Chorus Aviation reported an adjusted net income from continuing operations of C$10.6 million for Q4 2024.
- The financial data presented is based on Chorus’s audited consolidated financial statements for the year ending December 31, 2024.
A look at Chorus Aviation Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 1 | |
| Growth | 2 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have provided insights into the long-term outlook for Chorus Aviation, indicating a promising future. With a strong Value score of 4, Chorus Aviation is deemed to be undervalued compared to its intrinsic worth, presenting a potentially attractive investment opportunity. Additionally, the company’s Momentum score of 4 suggests a positive trend in its stock performance, indicating growing investor interest and confidence in the company’s prospects.
However, despite these strengths, Chorus Aviation received lower scores in other areas. The company’s Dividend score of 1 reflects a lower-than-average dividend yield, potentially impacting income-oriented investors. Similarly, with Growth and Resilience scores of 2, Chorus Aviation may face challenges in terms of future growth opportunities and ability to withstand economic fluctuations. Investors considering Chorus Aviation should weigh these factors against the company’s strong valuation and positive momentum.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
